Dr. Nekhlyudov is an Associate Professor at Harvard Medical School as well as a practicing internist at the Brigham & Women's Hospital Primary Care Associates, Longwood. She is Clinical Director, Internal Medicine for Cancer Survivors at the Dana Farber Cancer Institute, offering clinical consultations for long term cancer survivors at the David B. Perini Quality of Life Clinic and the Adult Survivorship Program. Dr. Nekhlyudov is particularly interested in improving the care of cancer survivors and the interplay between primary and oncology care. She has published close to 100 original manuscripts, editorials, guideline/position papers, and book chapters. She has been invited to speak at numerous national and international meetings.

Nekhlyudov served on the Institute of Medicine committee on cancer care quality, and was on the planning committee of the 2017 National Cancer Policy Forum of the National Academies of Sciences, Engineering and Medicine Workshop on “Long-term Survivorship Care after Cancer Treatment.” Dr. Nekhlyudov has served on several American Society of Clinical Oncology Committees and Task Forces, and is a member of the National Comprehensive Cancer Network Guideline Committee. She is a member of the Executive Committee of the Cancer and Primary Care International Research Network (Ca-PRI) and was Organizer/Chair of the 2016 Annual Meeting in Boston, Massachusetts. Locally, Dr. Nekhlyudov serves on the Advisory Board of the Massachusetts Cancer Registry and the Survivorship Work Group at the Massachusetts Comprehensive Cancer Prevention and Control Network.

Dr. Nekhlyudov is co-Director of the Harvard Medical School-Dana Farber Cancer Institute Continuing Medical Education Program on cancer survivorship and has developed a website offering cancer survivorship resources to primary care providers - www.cancerpcp.org. In recognition of her distinguished contributions to cancer health services research and clinical care for cancer survivors, Dr. Nekhlyudov received the 2014 Saul Horowitz, Jr. Memorial Award from the Mount Sinai School of Medicine and in 2015, she was elected as Fellow of the American College of Physicians. Dr. Nekhlyudov teaches at Harvard Medical School and has served as a continuity clinic preceptor in the Brigham and Women’s Hospital Residency Program.

Prior to moving to the Brigham & Women's Hospital in 2015, she spent over 15 years as a primary care physician at Harvard Vanguard Medical Associates and was on faculty at the Department of Population Medicine at Harvard Medical School where she was Director of Cancer Research, Director of the NCI-funded Community Practice Research Core at the Dana-Farber/Harvard Cancer Center and Site Principal Investigator for the NCI-funded HMO Cancer Research Network.

Dr. Nekhlyudov is a 2017-2018 NCI/AcademyHealth Healthcare Delivery Research Visiting Scholar. To learn more about the NCI/AcademyHealth Healthcare Delivery Research Visiting Scholar Program visit www.academyhealth.org/NCI.

Authored by Larissa Nekhlyudov, M.D., M.P.H.